Skip to main content
Premium Trial:

Request an Annual Quote

GeneNews Gains ISO Certification for Product Development Quality System

NEW YORK (GenomeWeb News) — GeneNews said today it has received certification from the International Organization for Standardization for its Quality Management System, which covers both design and development of in vitro diagnostic test kits that are used in managing colorectal cancer.

Meeting the ISO requirements will help GeneNews gain international regulatory approval for its blood-based molecular diagnostics products, said company CEO Wayne Marshall.

Marshall said that the certification, which was earned after an audit in December 2007 by TUV SUD America, will be an important step in the company’s commercialization strategy.

The company’s first product in development is the ColonSentry, a blood-based biomarker test designed to identify current risk of colorectal cancer. GeneNews said it is using its Sentinel Principle technology in other areas, including cardiovascular disease, arthritis, and neurological disorders.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.